Skip to content
R

Razieh Sabet

Publications (6)

QSAR, Docking Study of Isatin Analogues as Anti-bacterial Agents for Design New Compounds

Razieh Sabet & Isar Jafroudi · Journal of Pharmaceutical Research International · 2019

Computational chemistry is unique method in drug discovery which reduce cost. In this study 86 molecules containing isatin core were subjected to quantitative structure-activity relationship analysis and docking study to find the structure requirements for ligand binding. The str...

Open access Research Article 10.9734/jpri/2019/v31i530314

QSAR and Docking Study of Isatin Analogues as Cytotoxic Agents

Razieh Sabet, Soghra Khabnadideh, Dara Fathi & Leila Emami · Journal of Pharmaceutical Research International · 2019

Computational chemistry is a unique method in the drug discovery process?? Explain Why?. In this study 109 molecules containing the isatin backbone were subjected to quantitative structure-activity relationship analysis to find the structure requirements for ligand binding. The s...

Open access Research Article 10.9734/jpri/2019/v27i530184

Application of Substituent Electronic Descriptors QSAR Model of 2-amino-6-arylsulfonylbenzonitriles as HIV-1 Reverse Transcriptase Inhibitors based on the MOLMAP Approach

Razieh Sabet & Maryam Sabet · Asian Journal of Applied Chemistry Research · 2018

The HIV-1 reverse transcriptase (RT) is a major target for drug development. Inhibition of this enzyme has been one of the primary therapeutic strategies in suppressing the replication of HIV-1. A series of 2-amino-6-arylsulfonylbenzonitrile derivatives were subjected to quantita...

Open access Research Article 10.9734/ajacr/2018/v1i29617

Quantitative Structure Activity Relationship of New Isatin Analogues for Design New Compounds as Anti-breast Cancer

Soghra Khabnadideh, Razieh Sabet, Hasti Pour Naghz & Masoumeh Divar · Journal of Pharmaceutical Research International · 2019

Breast cancer is the most common diagnosed cancer and the leading cause of related death in woman across the world. Nowadays, there are many effective chemotherapeutic agents used in the treatment of breast cancer, however due to the high side effects of these drugs, there is sti...

Open access Research Article 10.9734/jpri/2019/v28i530217

Quantitative Structure–Activity Relationship and Molecular Docking Studies of Imidazolopyrimidine Amides as Potent Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Leila Emami, Razieh Sabet, Amirhossein Sakhteman & Mehdi Khoshnevis Zade · Journal of Pharmaceutical Research International · 2019

Type 2 diabetes (T2DM) is a metabolic disorder disease and DPP-4 inhibitors are a class of oral hypoglycemic that blocks the dipeptidyl peptidase-4 (DPP-4) enzyme.  DPP-4 inhibitors reduce glucagon and blood glucose levels and don’t have side effects such as hypoglycemia or weigh...

Open access Research Article 10.9734/jpri/2019/v27i630186

Synthesis of Some Novel Semicarbazone and Thiosemicarbazone Derivatives of Isatin as Possible Biologically Active Agents

Masoumeh Divar, Ali Khalafi-Nezhad, Kamiar Zomorodian, Razieh Sabet, Zahra Faghih, Maryam Jamali, Hasti Pournaghz & Soghra Khabnadideh · Journal of Pharmaceutical Research International · 2017

Aims: The development of new beneficial agents is one of the crucial aims in medicinal chemistry. Isatin is considered as a vital class of bioactive compounds exhibiting different biological activities. A series of nine new Semicarbazone (12a-i) and six new Thiosemicarbazone (14a...

Open access Research Article 10.9734/JPRI/2017/35243